1. Home
  2. |Insights
  3. |IBJ/IJE Webinar - Practice Group Effective Dispute Resolution: Resolving disputes caused by the COVID-19 crisis – what options does the in-house lawyer have in the short and longer term?

IBJ/IJE Webinar - Practice Group Effective Dispute Resolution: Resolving disputes caused by the COVID-19 crisis – what options does the in-house lawyer have in the short and longer term?

Webinar | 07.03.20, 2:30 PM CEST - 4:00 PM CEST

As companies enter the post-COVID era, certain disagreements created by the crisis have not yet been resolved and new disputes linked to this unprecedented period are seeing the light of day. 


This webinar for the Practice Group Effective Dispute Resolution, which is open exclusively for members of the IBJ/IJE, aims to take stock of the possible ways in which these disputes can be handled and allow you to be better prepared in the future. 


Apart from looking at the legal aspects, the speakers will also investigate less frequently used options, such as binding decision-making by third party moderators (a procedure that recently obtained the support of the Bar) and mediation.


Emmanuel Plasschaert and Kristof Roox from the law firm Crowell & Moring will take the lead and share their experience and practical advice during this session, which will focus on the particular problems and questions that in-house lawyers have come across.


For more information, please visit these areas: Antitrust and Competition — Brussels Practice, Corporate — Brussels Practice, Intellectual Property — Brussels Practice, Labor and Employment — Brussels Practice, Dispute Resolution — Brussels Practice, Dispute Resolution — Brussels Practice/Corporate and Commercial, Brussels Practice, Antitrust and Competition

Contact

Participants

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.

View All Insights